Plasma-Lyte addresses these clinically unmet needs and issues, bringing a balanced solution with sodium, potassium, magnesium and chloride levels similar to plasma7. The absence of calcium in the solution means, it can be administered before, during or after blood transfusion 6. Plasma-Lyte does not exacerbate metabolic acidosis, nor does it complicate the evaluation of metabolic acidosis 13. Plasma-Lyte reduces the risk of hyperchloremic acidosis compared to those receiving normal saline and does not adversely affect acid base status 1,2,3,4,5,8
Currently administered IV fluid therapies in India include Colloids (6% hydroxyethyl starch, albumin) and Crystalloids (Ringers Lactate, Ringer’s Acetate, Normal Saline). Fluid resuscitation with normal saline encompasses high levels of sodium and chloride and can result in detrimental clinical outcomes by causing hyperchloremic metabolic acidosis, reduced renal perfusion, and immune dysfunction, especially in major surgery1,5 .Some otherbalanced crystalloid solutions like Lactated Ringer’s solution cannot be co-administered with citrate preserved blood, as the calcium affects the anticoagulant properties of citrate 6. Large volume infusion of Ringer’s lactate can also lead to complications of hyponatremia and acidosis as seen during major spine surgery9.
Hydroxyethyl starch (HES), a commonly used colloid in fluid therapy in critically ill patients, is associated with serious safety issues leading to increased need for renal replacement therapy, increased mortality and higher risk of kidney dysfunction 10, 11.
Plasma-Lyte is currently available in 38 countries. CCI Newswire
New Delhi, May 17, 2024: In response to the growing need for specialized pediatric care,…
Achieves significant advancement in Cancer Treatment to Enhance Quality of Life As per the National…
-An 11-year-old boy from Yemen and a 34-year-old man from Bengaluru, both suffered from end-stage…
Mumbai, 14th May 2024 – As part of its dedication to exceptional patient care, American Oncology…
Mumbai, May 11, 2024: In a landmark move for Indian healthcare, the introduction of Second…
Bengaluru, May 08, 2024: Cancer remains the illness most feared across the globe. But to combat…